PYCR1 and colorectal carcinoma: In summary, our data demonstrate that mitochondrial PYCR genes sustain proliferation and survival of CRC cells and suggest a pro-tumorigenic role for these genes in CRC, emphasizing the notion that proline biosynthesis is a promising target for the development of novel anti-cancer therapies [10].